MYGN Latest Press Releases

-- October 22, 2026 --

Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers Globe Newswire 9:05 AM

-- October 20, 2026 --

Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp Globe Newswire 8:30 AM

-- October 15, 2026 --

Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026 Globe Newswire 4:05 PM

-- October 8, 2026 --

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology PRNewswire 9:01 AM

Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology Globe Newswire 9:00 AM

-- September 16, 2026 --

Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial Globe Newswire 8:00 AM

-- August 27, 2026 --

Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference Globe Newswire 9:05 AM

-- August 13, 2026 --

MYGN SHAREHOLDER ALERT: Myriad Genetics Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations Business Wire 8:00 PM

-- August 10, 2026 --

Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky PRNewswire 10:07 AM

-- August 8, 2026 --

MYGN Investors Have Opportunity to Join Myriad Genetics, Inc. Fraud Investigation with SBS Law Business Wire 2:57 PM

-- August 7, 2026 --

MYRIAD INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Myriad Genetics, Inc. on Behalf of Myriad Stockholders and Encourages Investors to Contact the Firm Globe Newswire 2:54 PM

-- August 6, 2026 --

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Myriad Genetics (MYGN) Globe Newswire 10:09 AM

-- August 5, 2026 --

MYRIAD GENETICS, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud Globe Newswire 8:00 PM

MYGN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Myriad Genetics (MYGN) Business Wire 10:07 AM

-- August 4, 2026 --

Myriad Genetics, Inc. (MYGN) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel Globe Newswire 11:27 AM

MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics PRNewswire 10:07 AM

-- August 3, 2026 --

Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN) PRNewswire 6:14 PM

-- July 30, 2026 --

Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability Globe Newswire 4:05 PM

-- July 23, 2026 --

Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026 Globe Newswire 9:05 AM

-- July 21, 2026 --

Myriad Genetics Launches FirstGene Multiple Prenatal Screen Globe Newswire 9:05 AM

-- July 2, 2026 --

New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad's Prolaris Biopsy Test in Localized Prostate Cancer Globe Newswire 9:05 AM

-- June 23, 2026 --

Myriad Genetics Expands Availability of Precise MRD for Colorectal, Renal and Breast Cancers, Supported by New Publication Globe Newswire 9:05 AM

-- June 2, 2026 --

Myriad Genetics Names Raj Jampa as New Chief Technology Officer Globe Newswire 9:05 AM

Market Data Delayed 15 Minutes